TY  - GEN
AU  - Wilson,W H
AU  - Jamis-Dow,C
AU  - Bryant,G
AU  - Balis,F M
AU  - Klecker,R W
AU  - Bates,S E
AU  - Chabner,B A
AU  - Steinberg,S M
AU  - Kohler,D R
AU  - Wittes,R E
TI  - Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy
SN  - 0732-183X
PY  - 1995///0911
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Cross-Over Studies
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Doxorubicin
KW  - Drug Resistance, Multiple
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Hypotension
KW  - chemically induced
KW  - Leukocyte Count
KW  - drug effects
KW  - Lymphoma
KW  - blood
KW  - Male
KW  - Middle Aged
KW  - Neutrophils
KW  - Platelet Count
KW  - Prednisone
KW  - Sarcoma
KW  - Stereoisomerism
KW  - Verapamil
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1200/JCO.1995.13.8.1985
ER  -